These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22429589)

  • 1. Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein coupling.
    Zheng H; Pearsall EA; Hurst DP; Zhang Y; Chu J; Zhou Y; Reggio PH; Loh HH; Law PY
    BMC Cell Biol; 2012 Mar; 13():6. PubMed ID: 22429589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src phosphorylation of micro-receptor is responsible for the receptor switching from an inhibitory to a stimulatory signal.
    Zhang L; Zhao H; Qiu Y; Loh HH; Law PY
    J Biol Chem; 2009 Jan; 284(4):1990-2000. PubMed ID: 19029294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of palmitoylation of cysteine 415 in functional coupling CB
    Oddi S; Totaro A; Scipioni L; Dufrusine B; Stepniewski TM; Selent J; Maccarrone M; Dainese E
    Biotechnol Appl Biochem; 2018 Jan; 65(1):16-20. PubMed ID: 28722168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK506-binding protein 12 modulates μ-opioid receptor phosphorylation and protein kinase C(ε)-dependent signaling by its direct interaction with the receptor.
    Qiu Y; Zhao W; Wang Y; Xu JR; Huie E; Jiang S; Yan YH; Loh HH; Chen HZ; Law PY
    Mol Pharmacol; 2014 Jan; 85(1):37-49. PubMed ID: 24113748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranslation modification of G protein-coupled receptor in relationship to biased agonism.
    Zheng H; Loh HH; Law PY
    Methods Enzymol; 2013; 522():391-408. PubMed ID: 23374194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of mTOR Activity by μ-Opioid Receptor is Dependent upon the Association of Receptor and FK506-Binding Protein 12.
    Wang Y; Ge YH; Wang YX; Liu T; Law PY; Loh HH; Chen HZ; Qiu Y
    CNS Neurosci Ther; 2015 Jul; 21(7):591-8. PubMed ID: 26096047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular details of dimerization kinetics reveal negligible populations of transient µ-opioid receptor homodimers at physiological concentrations.
    Meral D; Provasi D; Prada-Gracia D; Möller J; Marino K; Lohse MJ; Filizola M
    Sci Rep; 2018 May; 8(1):7705. PubMed ID: 29769636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization.
    Chu J; Zheng H; Zhang Y; Loh HH; Law PY
    Cell Signal; 2010 Apr; 22(4):684-96. PubMed ID: 20043990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoylation Strengthens Cholesterol-dependent Multimerization and Fusion Activity of Human Cytomegalovirus Glycoprotein B (gB).
    Patrone M; Coroadinha AS; Teixeira AP; Alves PM
    J Biol Chem; 2016 Feb; 291(9):4711-22. PubMed ID: 26694613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of G protein-coupled receptors by palmitoylation and cholesterol.
    Goddard AD; Watts A
    BMC Biol; 2012 Mar; 10():27. PubMed ID: 22429402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioorthogonal click chemistry to assay mu-opioid receptor palmitoylation using 15-hexadecynoic acid and immunoprecipitation.
    Ebersole B; Petko J; Levenson R
    Anal Biochem; 2014 Apr; 451():25-7. PubMed ID: 24463015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2.
    Kuszak AJ; Pitchiaya S; Anand JP; Mosberg HI; Walter NG; Sunahara RK
    J Biol Chem; 2009 Sep; 284(39):26732-41. PubMed ID: 19542234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.
    Zhang P; Johnson PS; Zöllner C; Wang W; Wang Z; Montes AE; Seidleck BK; Blaschak CJ; Surratt CK
    Brain Res Mol Brain Res; 1999 Oct; 72(2):195-204. PubMed ID: 10529478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide.
    Yang Y; Li Q; He QH; Han JS; Su L; Wan Y
    Exp Mol Med; 2018 May; 50(5):1-16. PubMed ID: 29780163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid Addiction and Opioid Receptor Dimerization: Structural Modeling of the OPRD1 and OPRM1 Heterodimer and Its Signaling Pathways.
    Wu B; Hand W; Alexov E
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
    Melkes B; Hejnova L; Novotny J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-dependent spatiotemporal signaling profiles of the μ-opioid receptor are controlled by distinct protein-interaction networks.
    Civciristov S; Huang C; Liu B; Marquez EA; Gondin AB; Schittenhelm RB; Ellisdon AM; Canals M; Halls ML
    J Biol Chem; 2019 Nov; 294(44):16198-16213. PubMed ID: 31515267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-Palmitoylation of a Novel Site in the β2-Adrenergic Receptor Associated with a Novel Intracellular Itinerary.
    Adachi N; Hess DT; McLaughlin P; Stamler JS
    J Biol Chem; 2016 Sep; 291(38):20232-46. PubMed ID: 27481942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating micro-opioid receptor phosphorylation switches agonist-dependent signaling as reflected in PKCepsilon activation and dendritic spine stability.
    Zheng H; Chu J; Zhang Y; Loh HH; Law PY
    J Biol Chem; 2011 Apr; 286(14):12724-33. PubMed ID: 21292762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitoylation of the human prostacyclin receptor. Functional implications of palmitoylation and isoprenylation.
    Miggin SM; Lawler OA; Kinsella BT
    J Biol Chem; 2003 Feb; 278(9):6947-58. PubMed ID: 12488443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.